Study of ASP7374, Cell-culture-derived Influenza Vaccine
Clinical trial NCT01961947 · COMPLETED
Trial details
- NCT number
- NCT01961947
- Sponsor
- UMN Pharma Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2013-11-01
- Enrollment
- 900
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.